Anti-topoisomerase-positive limited systemic sclerosis has a propensity for interstitial lung disease but is linked to favourable prognosis

Rheumatology (Oxford). 2022 Nov 28;61(12):4585-4586. doi: 10.1093/rheumatology/keac287.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Humans
  • Lung Diseases, Interstitial* / etiology
  • Prognosis
  • Scleroderma, Systemic*